Patel Naimish

Patel Naimish is listed in filings as Chief Medical Officer at CRISPR Therapeutics AG-Common Shares. This profile follows SEC Form 4 activity through Jun 2, 2026, including sale activity and purchase activity. Recent filings connect the profile to CRISPR Therapeutics AG-Common Shares (CRSP). The current snapshot covers public activity from Oct 18, 2024 to Jun 2, 2026. Reported amounts are shown as $210.6K to $152.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.